RESEARCH-USE BIOSIMILAR ANTIBODY
Fianlimab
Monoclonal antibody · IgG4
Fianlimab (REGN3767) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells and has anti-tumour activity.
TARGETLAG3
YMonoclonal antibody
CATALOGSC-BS-549
CATALOG NUMBERSC-BS-549
MOLECULAR WEIGHTApprox. 146.46 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Fianlimab (REGN3767) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells and has anti-tumour activity.
Fianlimab is a recombinant research-use antibody directed against LAG3.